But the indices are in a trading range and it really boils down to finding the right vehicles to ride.

Don't Get Out of Joint Real Money Pro($)

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
China has several efficient ways to deal with its debt problem.

Back to Basics in Biotech Real Money Pro($)

Stop losses do not work in this part of the market.
ACAD looks strong enough for a rally at least to the upper $30s.
Fearlessness has always led to corrections.

A Roundup of My Open Positions Real Money Pro($)

Update on the last few Action Alerts Options trades.
UNH continues to rise, and we have a new price target and stop level.
The ground is shifting in the biotech and pharma space.
The producer of heart pumps also is an interesting name for the longer term.

Columnist Conversations

we like this chart here, it appears ready to move higher. BOUGHT BZUN OCT 35 CALL AT 3.40
Large-cap, high-quality McKesson (MCK) is too cheap now, at $147.51 or so. The stock hit $243.60 more than 2.5...
View Chart »  View in New Window » View Chart » 


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.